Detecting unexpected adverse drug reactions in children

Pediatric Drugs

Volumn 13, Issue 2, 2011, Pages 71-73

  Star, Kristina ^a,b  

^a UPPSALA MONITORING CENTRE   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ESCITALOPRAM; MONTELUKAST; RISPERIDONE; VENLAFAXINE;

ALLERGY; ANXIETY DISORDER; DEPRESSION; DISEASE EXACERBATION; DRUG MONITORING; DRUG SAFETY; DRUG SUBSTITUTION; DRUG SURVEILLANCE PROGRAM; DRUG WITHDRAWAL; EMERGENCY WARD; EXERCISE INDUCED ASTHMA; FOOD AND DRUG ADMINISTRATION; HEALTH CARE PERSONNEL; HEALTH CARE PRACTICE; HUMAN; MENTAL HEALTH CARE; MOOD CHANGE; PRIORITY JOURNAL; REVIEW; SEASONAL ALLERGY; SIDE EFFECT; SLEEP PATTERN; SUICIDE ATTEMPT;

ACETATES; ADOLESCENT; ADVERSE DRUG REACTION REPORTING SYSTEMS; ASTHMA, EXERCISE-INDUCED; CHILD; DRUG TOXICITY; HUMANS; HYPERSENSITIVITY; MALE; QUINOLINES; RESEARCH REPORT;

EID: 79952122298     PISSN: 11745878     EISSN: 11792019     Source Type: Journal    
DOI: 10.2165/11589100-000000000-00000     Document Type: Review

References (14)

1. Finney DJ. An international drug safety program. J New Drugs 1963 Sep-Oct; 15: 262-5
2. Lindquist M. Vigibase, the WHO global ICSR database system: basic facts. Drug Inf J 2008; 42 (5): 409-19
3. US Food and Drug Administration. Leukotriene inhibitors: montelukast (marketed as Singulair), zafirlukast (marketed as Accolate), and zileuton (marketed as Zyflo and Zyflo CR) [online]. Available from URL: http:// www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHuman MedicalProducts/ucm166246.htm [Accessed 2010 Dec 3]
4. Bäckström M, Mjörndal T, Dahlqvist R, et al. Attitudes to reporting adverse drug reactions in n (Pubitemid 32204497)
5. Star K, Norén GN, Nordin K, et al. Adverse drug reactions reported for children worldwide: an exploratory study using VigiBase. Drug Saf. In press
6. Edwards IR, Biriell C. Harmonisation in pharmacovigilance. Drug Saf 1994 Feb; 10 (2): 93-102 (Pubitemid 24045719)
7. Bate A, Lindquist M, Edwards IR, et al. A Bayesian neural network method for adverse drug reaction signal generation. Eur J Clin Pharmacol 1998; 54 (4): 315-21 (Pubitemid 28328016)
8. Lindquist M, Stahl M, Bate A, et al. Aretrospective evaluation of a datamining approach to aid finding new adverse drug reaction signals in the WHO international database. Drug Saf 2000; 23 (6): 533-42 (Pubitemid 32001514)
9. Norén GN, Bate A, Orre R, et al. Extending the methods used to screen the WHO drug safety database towards analysis of complex associations and improved accuracy for rare events. Stat Med 2006 Nov 15; 25 (21): 3740-57 (Pubitemid 44613906)
10. Ståhl M, Lindquist M, Edwards IR, et al. Introducing triage logic as a new strategy for the detection of signals in the WHO Drug Monitoring Database. Pharmacoepidemiol Drug Saf 2004 Jun; 13 (6): 355-63 (Pubitemid 38787154)
11. Sanz EJ. Serious cardiac effects of atomoxetine [restricted document]. WHO Signal 2005 Nov
12. Sanz EJ. SSRI: neonatal withdrawal syndrome [restricted document]. WHO Signal 2001 Dec
13. Sanz EJ, De-las-Cuevas C, Kiuru A, et al. Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis. Lancet 2005 Feb 5-11; 365 (9458): 482-7 (Pubitemid 40215730)
14. Hazell L, Shakir SA. Under-reporting of adverse drug reactions: a systematic review. Drug Saf 2006; 29 (5): 385-96